Contemporary management of the neck in nasopharyngeal carcinoma
dc.contributor.author | Ng, Wai Tong | |
dc.contributor.author | Tsang, Raymond K. Y. | |
dc.contributor.author | Beitler, Jonathan J. | |
dc.contributor.author | Bree, Remco | |
dc.contributor.author | Coca‐pelaz, Andrés | |
dc.contributor.author | Eisbruch, Avraham | |
dc.contributor.author | Guntinas‐lichius, Orlando | |
dc.contributor.author | Lee, Anne W. M. | |
dc.contributor.author | Mäkitie, Antti A. | |
dc.contributor.author | Mendenhall, William M. | |
dc.contributor.author | Nuyts, Sandra | |
dc.contributor.author | Rinaldo, Alessandra | |
dc.contributor.author | Robbins, K. Thomas | |
dc.contributor.author | Rodrigo, Juan P. | |
dc.contributor.author | Silver, Carl E. | |
dc.contributor.author | Simo, Ricard | |
dc.contributor.author | Smee, Robert | |
dc.contributor.author | Strojan, Primož | |
dc.contributor.author | Takes, Robert P. | |
dc.contributor.author | Ferlito, Alfio | |
dc.date.accessioned | 2021-06-02T21:05:18Z | |
dc.date.available | 2022-07-02 17:05:18 | en |
dc.date.available | 2021-06-02T21:05:18Z | |
dc.date.issued | 2021-06 | |
dc.identifier.citation | Ng, Wai Tong; Tsang, Raymond K. Y.; Beitler, Jonathan J.; Bree, Remco; Coca‐pelaz, Andrés ; Eisbruch, Avraham; Guntinas‐lichius, Orlando ; Lee, Anne W. M.; Mäkitie, Antti A. ; Mendenhall, William M.; Nuyts, Sandra; Rinaldo, Alessandra; Robbins, K. Thomas; Rodrigo, Juan P.; Silver, Carl E.; Simo, Ricard; Smee, Robert; Strojan, Primož ; Takes, Robert P.; Ferlito, Alfio (2021). "Contemporary management of the neck in nasopharyngeal carcinoma." Head & Neck 43(6): 1949-1963. | |
dc.identifier.issn | 1043-3074 | |
dc.identifier.issn | 1097-0347 | |
dc.identifier.uri | https://hdl.handle.net/2027.42/167758 | |
dc.description.abstract | Up to 85% of the patients with nasopharyngeal carcinoma present with regional nodal metastasis. Although excellent nodal control is achieved with radiotherapy, a thorough understanding of the current TNM staging criteria and pattern of nodal spread is essential to optimize target delineation and minimize unnecessary irradiation to adjacent normal tissue. Selective nodal irradiation with sparing of the lower neck and submandibular region according to individual nodal risk is now emerging as the preferred treatment option. There has also been continual refinement in staging classification by incorporating relevant adverse nodal features. As for the uncommon occurrence of recurrent nodal metastasis after radiotherapy, surgery remains the standard of care. | |
dc.publisher | John Wiley & Sons, Inc. | |
dc.subject.other | radiotherapy | |
dc.subject.other | prognosis | |
dc.subject.other | nodal metastasis | |
dc.subject.other | nasopharyngeal carcinoma | |
dc.subject.other | surgery | |
dc.subject.other | staging | |
dc.title | Contemporary management of the neck in nasopharyngeal carcinoma | |
dc.type | Article | |
dc.rights.robots | IndexNoFollow | |
dc.subject.hlbsecondlevel | Otolaryngology | |
dc.subject.hlbtoplevel | Health Sciences | |
dc.description.peerreviewed | Peer Reviewed | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/167758/1/hed26685_am.pdf | |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/167758/2/hed26685.pdf | |
dc.identifier.doi | 10.1002/hed.26685 | |
dc.identifier.source | Head & Neck | |
dc.identifier.citedreference | Li X, Lin C, Yan J, et al. Establishment of a prognostic scoring model for regional recurrent nasopharyngeal carcinoma after neck dissection. Cancer Biol Med. 2020; 17: 227 - 236. | |
dc.identifier.citedreference | Li JG, Venigalla P, Leeman JE, et al. Patterns of nodal failure after intensity modulated radiotherapy for nasopharyngeal carcinoma. Laryngoscope. 2017; 127: 377 - 382. | |
dc.identifier.citedreference | Xue F, Hu C, He X. Long- term patterns of regional failure for nasopharyngeal carcinoma following intensity- modulated radiation therapy. J Cancer. 2017; 8: 993 - 999. | |
dc.identifier.citedreference | Cao CN, Luo JW, Gao L, et al. Clinical characteristics and patterns of failure in the parotid region after intensity- modulated radiotherapy for nasopharyngeal carcinoma. Oral Oncol. 2013; 49: 611 - 614. | |
dc.identifier.citedreference | Chen FP, Zhou GQ, Qi ZY, et al. Prognostic value of cervical nodal tumor volume in nasopharyngeal carcinoma: analysis of 1230 patients with positive cervical nodal metastasis. PLoS One. 2017; 12: e0176995. | |
dc.identifier.citedreference | Yuan H, Ai QY, Kwong DL, et al. Cervical nodal volume for prognostication and risk stratification of patients with nasopharyngeal carcinoma, and implications on the TNM- staging system. Sci Rep. 2017; 7: 10387. | |
dc.identifier.citedreference | Li JY, Huang CL, Luo WJ, et al. An integrated model of the gross tumor volume of cervical lymph nodes and pretreatment plasma Epstein- Barr virus DNA predicts survival of nasopharyngeal carcinoma in the intensity- modulated radiotherapy era: a big- data intelligence platform- based analysis. Ther Adv Med Oncol. 2019; 11: 1758835919877729. | |
dc.identifier.citedreference | Shi Q, Shen C, Kong L, et al. Involvement of both cervical lymph nodes and retropharyngeal lymph nodes has prognostic value for N1 patients with nasopharyngeal carcinoma. Radiat Oncol. 2014; 9: 7. | |
dc.identifier.citedreference | Tang LL, Guo R, Zhou G, et al. Prognostic value and staging classification of retropharyngeal lymph node metastasis in nasopharyngeal carcinoma patients treated with intensity- modulated radiotherapy. PLoS One. 2014; 9: e108375. | |
dc.identifier.citedreference | Huang L, Zhang Y, Liu Y, et al. Prognostic value of retropharyngeal lymph node metastasis laterality in nasopharyngeal carcinoma and a proposed modification to the UICC/AJCC N staging system. Radiother Oncol. 2019; 140: 90 - 97. | |
dc.identifier.citedreference | Mao YP, Liang SB, Liu LZ, et al. The N staging system in nasopharyngeal carcinoma with radiation therapy oncology group guidelines for lymph node levels based on magnetic resonance imaging. Clin Cancer Res. 2008; 14: 7497 - 7503. | |
dc.identifier.citedreference | Tang L, Li L, Mao Y, et al. Retropharyngeal lymph node metastasis in nasopharyngeal carcinoma detected by magnetic resonance imaging: prognostic value and staging categories. Cancer. 2008; 113: 347 - 354. | |
dc.identifier.citedreference | Xu Y, Chen X, Zhang M, et al. Prognostic effect of parotid area lymph node metastases after preliminary diagnosis of nasopharyngeal carcinoma: a propensity score matching study. Cancer Med. 2017; 6: 2213 - 2221. | |
dc.identifier.citedreference | Zhang Y, Zhang ZC, Li WF, et al. Prognosis and staging of parotid lymph node metastasis in nasopharyngeal carcinoma: an analysis in 10,126 patients. Oral Oncol. 2019; 95: 150 - 156. | |
dc.identifier.citedreference | Ai QY, King AD, Poon DMC, et al. Extranodal extension is a criterion for poor outcome in patients with metastatic nodes from cancer of the nasopharynx. Oral Oncol. 2019; 88: 124 - 130. | |
dc.identifier.citedreference | Lu T, Hu Y, Xiao Y, et al. Prognostic value of radiologic extranodal extension and its potential role in future N classification for nasopharyngeal carcinoma. Oral Oncol. 2019; 99: 104438. | |
dc.identifier.citedreference | Lan M, Huang Y, Chen CY, et al. Prognostic value of cervical nodal necrosis in nasopharyngeal carcinoma: analysis of 1800 patients with positive cervical nodal metastasis at MR imaging. Radiology. 2015; 276: 536 - 544. | |
dc.identifier.citedreference | Luo Y, Ren J, Zhou P, et al. Cervical nodal necrosis is an independent survival predictor in nasopharyngeal carcinoma: an observational cohort study. Onco Targets Ther. 2016; 9: 6775 - 6783. | |
dc.identifier.citedreference | Lu L, Wei X, Li YH, Li WB. Sentinel node necrosis is a negative prognostic factor in patients with nasopharyngeal carcinoma: a magnetic resonance imaging study of 252 patients. Curr Oncol. 2017; 24: e220 - e225. | |
dc.identifier.citedreference | Feng Y, Cao C, Hu Q, Chen X. Prognostic value and staging classification of lymph nodal necrosis in nasopharyngeal carcinoma after intensity- modulated radiotherapy. Cancer Res Treat. 2019; 51: 1222 - 1230. | |
dc.identifier.citedreference | Zhang LL, Li JX, Zhou GQ, et al. Influence of cervical node necrosis of different grades on the prognosis of nasopharyngeal carcinoma patients treated with intensity- modulated radiotherapy. J Cancer. 2017; 8: 959 - 966. | |
dc.identifier.citedreference | Xie C, Li H, Yan Y, et al. A nomogram for predicting distant metastasis using nodal- related features among patients with nasopharyngeal carcinoma. Front Oncol. 2020; 10: 616. | |
dc.identifier.citedreference | Chan JY, Chan RC, Chow VL, et al. Efficacy of fine- needle aspiration in diagnosing cervical nodal metastasis from nasopharyngeal carcinoma after radiotherapy. Laryngoscope. 2013; 123: 134 - 139. | |
dc.identifier.citedreference | Wei WI, Mok VW. The management of neck metastases in nasopharyngeal cancer. Curr Opin Otolaryngol Head Neck Surg. 2007; 15: 99 - 102. | |
dc.identifier.citedreference | Mehanna H, Wong WL, McConkey CC, et al. PET- CT surveillance versus neck dissection in advanced head and neck cancer. N Engl J Med. 2016; 374: 1444 - 1454. | |
dc.identifier.citedreference | Chan JY, Chow VL, Wong ST, Wei WI. Surgical salvage for recurrent retropharyngeal lymph node metastasis in nasopharyngeal carcinoma. Head Neck. 2013; 35: 1726 - 1731. | |
dc.identifier.citedreference | Petruzzi G, Zocchi J, Moretto S, et al. Transoral robotic retropharyngeal lymph node dissection in a recurrent head and neck carcinoma. Head Neck. 2019; 41: 4051 - 4053. | |
dc.identifier.citedreference | Liu YP, Wang SL, Zou X, et al. Transcervical endoscopic retropharyngeal lymph node (RPLN) dissection in nasopharyngeal carcinoma with RPLN recurrence. Head Neck. 2021; 43 ( 1 ): 98 - 107. | |
dc.identifier.citedreference | Pollard C 3rd, Nguyen TP, Ng SP, et al. Clinical outcomes after local field conformal reirradiation of patients with retropharyngeal nodal metastasis. Head Neck. 2017; 39: 2079 - 2087. | |
dc.identifier.citedreference | Tsang RK, Wei WI. Salvage surgery for nasopharyngeal cancer. World J Otorhinolaryngol Head Neck Surg. 2015; 1: 34 - 43. | |
dc.identifier.citedreference | Liu YP, Li H, You R, et al. Surgery for isolated regional failure in nasopharyngeal carcinoma after radiation: selective or comprehensive neck dissection. Laryngoscope. 2019; 129: 387 - 395. | |
dc.identifier.citedreference | Chen JY, Zhang L, Ji QH, et al. Selective neck dissection for neck residue of nasopharyngeal carcinoma: a prospective study. J Craniomaxillofac Surg. 2015; 43: 1571 - 1576. | |
dc.identifier.citedreference | Chen H, Chen J, Wang M, Liao L. Retrospective study of selective neck dissection versus radical neck dissection as salvage therapy for patients with recurrent nasopharyngeal squamous cell carcinoma. J Craniomaxillofac Surg. 2014; 42: 1655 - 1658. | |
dc.identifier.citedreference | Wei WI, Ho WK, Cheng AC, et al. Management of extensive cervical nodal metastasis in nasopharyngeal carcinoma after radiotherapy: a clinicopathological study. Arch Otolaryngol Head Neck Surg. 2001; 127: 1457 - 1462. | |
dc.identifier.citedreference | Chan YW, Lee VH, Chow VL, et al. Extracapsular lymph node spread in recurrent nasopharyngeal carcinoma. Laryngoscope. 2011; 121: 2576 - 2580. | |
dc.identifier.citedreference | Yen KL, Hsu LP, Sheen TS, et al. Salvage neck dissection for cervical recurrence of nasopharyngeal carcinoma. Arch Otolaryngol Head Neck Surg. 1997; 123: 725 - 729. | |
dc.identifier.citedreference | Wei WI, Lam KH, Ho CM, et al. Efficacy of radical neck dissection for the control of cervical metastasis after radiotherapy for nasopharyngeal carcinoma. Am J Surg. 1990; 160: 439 - 442. | |
dc.identifier.citedreference | Peng H, Wang SJ, Yang X, et al. Modified radical neck dissection for residual neck disease after radiotherapy of nasopharyngeal carcinoma. Auris Nasus Larynx. 2014; 41: 485 - 490. | |
dc.identifier.citedreference | Zhang L, Zhu YX, Wang Y, et al. Salvage surgery for neck residue or recurrence of nasopharyngeal carcinoma: a 10- year experience. Ann Surg Oncol. 2011; 18: 233 - 238. | |
dc.identifier.citedreference | Chan RC, Chan JY. Impact of nodal ratio on survival in recurrent nasopharyngeal carcinoma. Head Neck. 2015; 37: 12 - 17. | |
dc.identifier.citedreference | Chen AM, Yoshizaki T, Velez MA, et al. Tolerance of the brachial plexus to high- dose Reirradiation. Int J Radiat Oncol Biol Phys. 2017; 98: 83 - 90. | |
dc.identifier.citedreference | van den Brekel MW, Stel HV, Castelijns JA, et al. Cervical lymph node metastasis: assessment of radiologic criteria. Radiology. 1990; 177: 379 - 384. | |
dc.identifier.citedreference | Lee AW, Ng WT, Pan JJ, et al. International guideline for the delineation of the clinical target volumes (CTV) for nasopharyngeal carcinoma. Radiother Oncol. 2018; 126: 25 - 36. | |
dc.identifier.citedreference | Simo R, Robinson M, Lei M, et al. Nasopharyngeal carcinoma: United Kingdom National Multidisciplinary Guidelines. J Laryngol Otol. 2016; 130: S97 - S103. | |
dc.identifier.citedreference | https://www.nrgoncology.org/Clinical-Trials/Protocol/nrg-hn001?filter=nrg-hn001. | |
dc.identifier.citedreference | Lee AW, Sze H, Ng WT. Is selective neck irradiation safe for node- negative nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys. 2013; 85 ( 4 ): 902 - 903. | |
dc.identifier.citedreference | Lee AW, Foo W, Law SC, et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. Hong Kong Med J. 1997; 3: 355 - 361. | |
dc.identifier.citedreference | Ho FC, Tham IW, Earnest A, et al. Patterns of regional lymph node metastasis of nasopharyngeal carcinoma: a meta- analysis of clinical evidence. BMC Cancer. 2012; 12: 98. | |
dc.identifier.citedreference | Sham JS, Choy D, Wei WI. Nasopharyngeal carcinoma: orderly neck node spread. Int J Radiat Oncol Biol Phys. 1990; 19: 929 - 933. | |
dc.identifier.citedreference | Lee AW, Ma BB, Ng WT, Chan AT. Management of nasopharyngeal carcinoma: current practice and future perspective. J Clin Oncol. 2015; 33: 3356 - 3364. | |
dc.identifier.citedreference | van den Bosch S, Dijkema T, Verhoef LC, et al. Patterns of recurrence in electively irradiated lymph node regions after definitive accelerated intensity modulated radiation therapy for head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 2016; 94: 766 - 774. | |
dc.identifier.citedreference | Shen G, Zhang W, Jia Z, et al. Meta- analysis of diagnostic value of 18F- FDG PET or PET/CT for detecting lymph node and distant metastases in patients with nasopharyngeal carcinoma. Br J Radiol. 2014; 87: 20140296. | |
dc.identifier.citedreference | Wang XS, Yan C, Hu CS, et al. Study of the medial group retropharyngeal node metastasis from nasopharyngeal carcinoma based on 3100 newly diagnosed cases. Oral Oncol. 2014; 50: 1109 - 1113. | |
dc.identifier.citedreference | Wang XS, Hu CS, Ying HM, et al. Patterns of retropharyngeal node metastasis in nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2009; 73: 194 - 201. | |
dc.identifier.citedreference | Xu P, Min Y, Blanchard P, et al. Incidence of small lymph node metastases in patients with nasopharyngeal carcinoma: clinical implications for prognosis and treatment. Head Neck. 2017; 39: 305 - 310. | |
dc.identifier.citedreference | Ho JH. Stage classification of nasopharyngeal carcinoma: a review. IARC Sci Publ. 1978; ( 20 ): 99 - 113. | |
dc.identifier.citedreference | Beahrs OH, Henson DE, Hutter RVP, Kennedy BJ, eds. Manual for Staging of Cancer. 4th ed. Philadelphia, PA: Lippincott; 1992. | |
dc.identifier.citedreference | Hong MH, Mai HQ, Min HQ, et al. A comparison of the Chinese 1992 and fifth- edition International Union against Cancer staging systems for staging nasopharyngeal carcinoma. Cancer. 2000; 89: 242 - 247. | |
dc.identifier.citedreference | Fleming ID, Cooper JS, Henson DE, et al., eds. AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott- Raven; 1997. | |
dc.identifier.citedreference | Pan J, Xu Y, Qiu S, et al. A comparison between the Chinese 2008 and the 7th edition AJCC staging systems for nasopharyngeal carcinoma. Am J Clin Oncol. 2015; 38: 189 - 196. | |
dc.identifier.citedreference | Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A, eds. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010. | |
dc.identifier.citedreference | Amin MB, Edge SB, Greene FL, et al., eds. AJCC Cancer Staging Manual. 8th ed. New York: Springer; 2017. | |
dc.identifier.citedreference | Brierley JD, Gospodarowicz MK, Wittekind C, et al., eds. TNM Classification of Malignant Tumours. 8th ed. Oxford: Wiley Blackwell; 2017. | |
dc.identifier.citedreference | Som PM, Curtin HD, Mancuso AA. An imaging- based classification for the cervical nodes designed as an adjunct to recent clinically based nodal classifications. Arch Otolaryngol Head Neck Surg. 1999; 125: 388 - 396. | |
dc.identifier.citedreference | Madu CN, Quint DJ, Normolle DP, et al. Definition of the supraclavicular and infraclavicular nodes: implications for three- dimensional CT- based conformal radiation therapy. Radiology. 2001; 221: 333 - 339. | |
dc.identifier.citedreference | Grégoire V, Eisbruch A, Hamoir M, Levendag P. Proposal for the delineation of the nodal CTV in the node- positive and the post- operative neck. Radiother Oncol. 2006; 79: 15 - 20. | |
dc.identifier.citedreference | Grégoire V, Ang K, Budach W, et al. Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol. 2014; 110: 172 - 181. | |
dc.identifier.citedreference | Ng WT, Lee AW, Kan WK, et al. N- staging by magnetic resonance imaging for patients with nasopharyngeal carcinoma: pattern of nodal involvement by radiological levels. Radiother Oncol. 2007; 82: 70 - 75. | |
dc.identifier.citedreference | Robbins KT, Clayman G, Levine PA, et al. Neck dissection classification update: revisions proposed by the American Head and Neck Society and the American Academy of Otolaryngology- Head and Neck Surgery. Arch Otolaryngol Head Neck Surg. 2002; 128: 751 - 758. | |
dc.identifier.citedreference | Li WF, Sun Y, Mao YP, et al. Proposed lymph node staging system using the International Consensus Guidelines for lymph node levels is predictive for nasopharyngeal carcinoma patients from endemic areas treated with intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys. 2013; 86: 249 - 256. | |
dc.identifier.citedreference | Yue D, Xu YF, Zhang F, et al. Is replacement of the supraclavicular fossa with the lower level classification based on magnetic resonance imaging beneficial in nasopharyngeal carcinoma? Radiother Oncol. 2014; 113: 108 - 114. | |
dc.identifier.citedreference | Pan JJ, Ng WT, Zong JF, et al. Proposal for the 8th edition of the AJCC/UICC staging system for nasopharyngeal cancer in the era of intensity- modulated radiotherapy. Cancer. 2016; 122: 546 - 558. | |
dc.identifier.citedreference | Ai QY, King AD, Mo FKF, et al. Staging nodal metastases in nasopharyngeal carcinoma: which method should be used to measure nodal dimension on MRI? Clin Radiol. 2018; 73: 640 - 646. | |
dc.identifier.citedreference | Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976- 1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys. 1992; 23: 261 - 270. | |
dc.identifier.citedreference | Lee N, Harris J, Garden AS, et al. Intensity- modulated radiation therapy with or without chemotherapy for nasopharyngeal carcinoma: radiation therapy oncology group phase II trial 0225. J Clin Oncol. 2009; 27: 3684 - 3690. | |
dc.identifier.citedreference | Lee NY, Zhang Q, Pfister DG, et al. Addition of bevacizumab to standard chemoradiation for locoregionally advanced nasopharyngeal carcinoma (RTOG 0615): a phase 2 multi- institutional trial. Lancet Oncol. 2012; 13: 172 - 180. | |
dc.identifier.citedreference | Tang L, Mao Y, Liu L, et al. The volume to be irradiated during selective neck irradiation in nasopharyngeal carcinoma: analysis of the spread patterns in lymph nodes by magnetic resonance imaging. Cancer. 2009; 115: 680 - 688. | |
dc.identifier.citedreference | Gao Y, Zhu G, Lu J, et al. Is elective irradiation to the lower neck necessary for N0 nasopharyngeal carcinoma? Int J Radiat Oncol Biol Phys. 2010; 77: 1397 - 1402. | |
dc.identifier.citedreference | He X, Pan Z, Guo X, et al. The pattern of relapse and survival of elective irradiation of the upper neck for stage N0 nasopharyngeal carcinoma. Radiat Oncol. 2012; 7: 35. | |
dc.identifier.citedreference | Sun JD, Chen CZ, Chen JZ, et al. Long term outcomes and prognostic factors of N0 stage nasopharyngeal carcinoma: a single institutional experience with 610 patients. Asian Pac J Cancer Prev. 2012; 13: 2101 - 2107. | |
dc.identifier.citedreference | Chen JZ, Le QT, Han F, et al. Results of a phase 2 study examining the effects of omitting elective neck irradiation to nodal levels IV and Vb in patients with N(0- 1) nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2013; 85: 929 - 934. | |
dc.identifier.citedreference | Li JG, Yuan X, Zhang LL, et al. A randomized clinical trial comparing prophylactic upper versus whole- neck irradiation in the treatment of patients with node- negative nasopharyngeal carcinoma. Cancer. 2013; 119: 3170 - 3176. | |
dc.identifier.citedreference | Zeng L, Sun XM, Chen CY, et al. Comparative study on prophylactic irradiation to the whole neck and to the upper neck for patients with neck lymph node- negative nasopharyngeal carcinoma. Head Neck. 2014; 36: 687 - 693. | |
dc.identifier.citedreference | Ou X, Shen C, Kong L, et al. Treatment outcome of nasopharyngeal carcinoma with retropharyngeal lymph nodes metastasis only and the feasibility of elective neck irradiation. Oral Oncol. 2012; 48: 1045 - 1050. | |
dc.identifier.citedreference | Chen M, Tang LL, Sun Y, et al. Treatment outcomes and feasibility of partial neck irradiation for patients with nasopharyngeal carcinoma with only retropharyngeal lymph node metastasis after intensity- modulated radiotherapy. Head Neck. 2014; 36: 468 - 473. | |
dc.identifier.citedreference | Hu W, Zhu G, Guan X, et al. The feasibility of omitting irradiation to the contralateral lower neck in stage N1 nasopharyngeal carcinoma patients. Radiat Oncol. 2013; 8: 230. | |
dc.identifier.citedreference | Chen J, Ou D, He X, Hu C. Sparing level Ib lymph nodes by intensity- modulated radiotherapy in the treatment of nasopharyngeal carcinoma. Int J Clin Oncol. 2014; 19: 998 - 1004. | |
dc.identifier.citedreference | Zhang F, Cheng YK, Li WF, et al. Investigation of the feasibility of elective irradiation to neck level Ib using intensity- modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis. BMC Cancer. 2015; 15: 709. | |
dc.identifier.citedreference | Li M, Huang XG, Yang ZN, et al. Effects of omitting elective neck irradiation to nodal level IB in nasopharyngeal carcinoma patients with negative level IB lymph nodes treated by intensity- modulated radiotherapy: a phase 2 study. Br J Radiol. 2016; 89: 20150621. | |
dc.identifier.citedreference | Ou X, Miao Y, Wang X, et al. The feasibility analysis of omission of elective irradiation to level IB lymph nodes in low- risk nasopharyngeal carcinoma based on the 2013 updated consensus guideline for neck nodal levels. Radiat Oncol. 2017; 12: 137. | |
dc.identifier.citedreference | Co JL, Mejia MBA, Dizon JMR. Evidence on effectiveness of upper neck irradiation versus whole neck irradiation as elective neck irradiation in node- negative nasopharyngeal cancer: a meta- analysis. J Glob Oncol. 2018; 4: 1 - 11. | |
dc.identifier.citedreference | Yi W, Li X, Liu Z, et al. A risk score model for the metastasis of level Ib lymph node based on the clinicopathological features of nasopharyngeal carcinoma in a large sample. Mol Clin Oncol. 2014; 2: 789 - 797. | |
dc.identifier.citedreference | Zeng L, Zhang Q, Ao F, et al. Risk factors and distribution features of level IB lymph nodes metastasis in nasopharyngeal carcinoma. Auris Nasus Larynx. 2019; 46: 457 - 464. | |
dc.identifier.citedreference | Huang L, Zhang W, Zhuang T, et al. Submandibular gland sparing in intensity- modulated radiotherapy for N0- stage nasopharyngeal carcinoma. Br J Radiol. 2014; 87: 20130651. | |
dc.identifier.citedreference | Wang X, Li L, Hu C, et al. Patterns of level II node metastasis in nasopharyngeal carcinoma. Radiother Oncol. 2008; 89: 28 - 32. | |
dc.identifier.citedreference | Wang X, Hu C, Ying H, et al. Patterns of lymph node metastasis from nasopharyngeal carcinoma based on the 2013 updated consensus guidelines for neck node levels. Radiother Oncol. 2015; 115: 41 - 45. | |
dc.identifier.citedreference | Zhang J, Pan L, Ren J, et al. Level IIb CTV delineation based on cervical fascia anatomy in nasopharyngeal cancer. Radiother Oncol. 2015; 115: 46 - 49. | |
dc.identifier.citedreference | Fisch UP. Cervical lymphography in cases of laryngo- pharyngeal carcinoma. J Laryngol Otol. 1964; 78: 715 - 726. | |
dc.identifier.citedreference | Givi B, Andersen PE. Rationale for modifying neck dissection. J Surg Oncol. 2008; 97: 674 - 682. | |
dc.identifier.citedreference | Halperin EC, Perez CA, Brady LW, eds. Perez and Brady’s Principle and Practice of Radiation Oncology. 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. | |
dc.identifier.citedreference | Bussels B, Maes A, Hermans R, et al. Recurrences after conformal parotid- sparing radiotherapy for head and neck cancer. Radiother Oncol. 2004; 72: 119 - 127. | |
dc.identifier.citedreference | Lin S, Pan J, Han L, et al. Nasopharyngeal carcinoma treated with reduced- volume intensity- modulated radiation therapy: report on the 3- year outcome of a prospective series. Int J Radiat Oncol Biol Phys. 2009; 75: 1071 - 1078. | |
dc.identifier.citedreference | Liu F, Luo T, Jin T, et al. Advantages of using reduced- volume intensity modulated radiation therapy for the treatment of nasopharyngeal carcinoma: a retrospective paired study. BMC Cancer. 2019; 19: 554. | |
dc.identifier.citedreference | Lin L, Lu Y, Wang XJ, et al. Delineation of neck clinical target volume specific to nasopharyngeal carcinoma based on lymph node distribution and the international consensus guidelines. Int J Radiat Oncol Biol Phys. 2018; 100: 891 - 902. | |
dc.identifier.citedreference | Li L, Li Y, Zhang J, et al. Optimization of cervical lymph node clinical target volume delineation in nasopharyngeal carcinoma: a single center experience and recommendation. Oncotarget. 2018; 9: 26980 - 26989. | |
dc.identifier.citedreference | Fletcher GH. Elective irradiation of subclinical disease in cancers of the head and neck. Cancer. 1972; 29: 1450 - 1454. | |
dc.identifier.citedreference | van den Bosch S, Vogel WV, Raaijmakers CP, et al. Implications of improved diagnostic imaging of small nodal metastases in head and neck cancer: radiotherapy target volume transformation and dose de- escalation. Radiother Oncol. 2018; 128: 472 - 478. | |
dc.identifier.citedreference | Kaanders J, van den Bosch S, Dijkema T, et al. Advances in cancer imaging require renewed radiotherapy dose and target volume concepts. Radiother Oncol. 2020; 148: 140 - 142. | |
dc.identifier.citedreference | Salama JK, Stenson KM, Kistner EO, et al. Induction chemotherapy and concurrent chemoradiotherapy for locoregionally advanced head and neck cancer: a multi- institutional phase II trial investigating three radiotherapy dose levels. Ann Oncol. 2008; 19: 1787 - 1794. | |
dc.identifier.citedreference | Deschuymer S, Nevens D, Duprez F, et al. Randomized clinical trial on reduction of radiotherapy dose to the elective neck in head and neck squamous cell carcinoma; update of the long- term tumor outcome. Radiother Oncol. 2020; 143: 24 - 29. | |
dc.identifier.citedreference | Cho WK, Oh D, Lee E, et al. Feasibility of selective neck irradiation with lower elective radiation dose in treating nasopharynx cancer patients. Cancer Res Treat. 2019; 51: 603 - 610. | |
dc.identifier.citedreference | Hung TM, Fan KH, Chen EY, et al. An elective radiation dose of 46 Gy is feasible in nasopharyngeal carcinoma treated by intensity- modulated radiotherapy: a long- term follow- up result. Medicine. 2017; 96: e6036. | |
dc.identifier.citedreference | Kasibhatla M, Kirkpatrick JP, Brizel DM. How much radiation is the chemotherapy worth in advanced head and neck cancer? Int J Radiat Oncol Biol Phys. 2007; 68: 1491 - 1495. | |
dc.identifier.citedreference | Stenmark MH, McHugh JB, Schipper M, et al. Nonendemic HPV- positive nasopharyngeal carcinoma: association with poor prognosis. Int J Radiat Oncol Biol Phys. 2014; 88: 580 - 588. | |
dc.working.doi | NO | en |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.